Renaissance BioScience Corp., a global leader in yeast bioengineering, has appointed Dr. James Tansey to its Board of Directors, the company announced on July 30, 2026. Dr. Tansey brings extensive experience in life sciences, technology commercialization, and corporate governance, which will be instrumental as Renaissance advances its platforms for yeast-produced RNA and virus-like particles (VLPs) in crop protection and broader health applications.
Dr. Tansey is a professor at the University of British Columbia’s Sauder School of Business and previously taught at Oxford University’s Saïd Business School. He is a founding team member at Gemina Labs, where he supports fundraising and business development, and serves on the boards of dynaCERT Inc. and Vanadium Resources Ltd. He is also a Senior Advisor to InBC, British Columbia’s $500 million strategic investment fund. His focus on impact investing and environmental sustainability aligns with Renaissance’s mission to address environmental challenges through innovative biotechnology.
Maurice Boucher, Renaissance Co-Founder and Executive Chairman, stated, “James brings an outstanding combination of entrepreneurial, strategic and governance experience, together with a strong track record of helping innovative technology companies grow. His expertise will be a valuable asset for Renaissance as we continue developing and globally commercializing our biotechnology platforms.”
Dr. Tansey commented, “Renaissance has developed an impressive portfolio of innovative technologies with significant commercial potential across agriculture, industrial biotechnology and animal and human health. I look forward to working with the Board and management team to help the company execute on its growth strategy and create long-term value.”
Dr. John Husnik, Renaissance Co-Founder, Director and CSO, added, “His experience building companies, securing investment, and helping innovative technologies move toward commercialization will complement our scientific expertise and support Renaissance as we continue developing and expanding our leading technology platforms.”
This appointment underscores Renaissance’s commitment to strengthening its governance and strategic capabilities as it advances its yeast bioengineering platforms. The company focuses on developing functional microorganisms for cost-effective solutions in agriculture, food, nutrition, and health, aiming to tackle environmental and industrial challenges.
